What is the Market's View on CEL-SCI Corporation (CVM) Stock's Price and Volume Trends Thursday?

Overall market sentiment has been high on CEL-SCI Corporation (CVM) stock lately. CVM receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

CEL-SCI Corporation has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on CVM!

See Full CVM Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With CVM Stock Today?

CEL-SCI Corporation (CVM) stock has fallen -20.31% while the S&P 500 has gained 0.15% as of 10:05 AM on Thursday, Nov 16. CVM has fallen -$0.59 from the previous closing price of $2.88 on volume of 935,342 shares. Over the past year the S&P 500 has risen 12.98% while CVM has fallen -31.95%. CVM lost -$0.78 per share in the over the last 12 months.

More About CEL-SCI Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia. Click Here to get the full Stock Report for CEL-SCI Corporation stock.